Innovate UK, GB: Transforming cancer therapeutics

23/11/2023

24/01/2024

The aim of this competition is to support innovation projects that focus on advancing next-generation immunotherapies for cancer or life-changing treatment options for childhood cancers. Your project can include: experimental evaluation at laboratory scale use of in vitro and in vivo models to evaluate proof of concept or safety exploration of potential production mechanisms prototyping product development planning intellectual property protection a demonstration of clinical utility and effectiveness a demonstration of safety and efficacy including phase 1 and 2 clinical trials regulatory planning Your project can focus on one or more of the following: next generation immunotherapies and immunomodulatory drugs manipulation of the tumour microenvironment to promote immune responses against solid tumours novel therapeutics that consider the unique characteristics of paediatric or young people’s cancers clinical decision support tools to optimise therapeutic dosing for children and young people This list is not intended to be exhaustive. Your project’s total costs must be between £150,000 and £4 million. The total grant request cannot exceed £2 million.

Carcinogenesis; Immunology; Immunotherapy; Medicine & Health; Paediatrics

Country of applicant institution United Kingdom Nationality of researcher Unspecified Applicant type Academic Institution; Commercial or Private Sector; Government or Public Sector; Non-profit Career stages Early Career and Emerging in Field; Mid-Career to Established in Field Eligibility Note Lead organisation To lead a project or work alone your organisation must be a UK registered micro, small or medium-sized enterprise (SME).